This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) rose 5.17% to $7.93 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.91% to 4,432.99 and Dow Jones Industrial Average falling 0.48% to 34,584.88. This was the stock's second consecutive day of gains. Ocugen Inc. closed $10.84 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Adverum Biotechnologies Inc. (ADVM) rose 3.59% to $2.31, Ocular Therapeutix Inc. (OCUL) rose 2.23% to $10.55, and Kodiak Sciences Inc. (KOD) rose 5.64% to $102.75. Trading volume (14.7 M) eclipsed its 50-day average volume of 13.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 17, 2021.
(END) Dow Jones Newswires
September 17, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.